263 related articles for article (PubMed ID: 10690468)
1. [Sleeping sickness in children at Bobo-Dioulasso Hospital Center: apropos of 3 cases].
Millogo A; Nacro B; Bonkoungou P; Sanou M; Traoré S; Traoré H; Tall F
Bull Soc Pathol Exot; 1999 Dec; 92(5):320-2. PubMed ID: 10690468
[TBL] [Abstract][Full Text] [Related]
2. [The epidemiology of human trypanosomiasis due to Trypanosoma gambiense in a focus of the Ivory Coast. I. The distribution of the disease in the population (author's transl)].
Stanghellini A; Duvallet G
Tropenmed Parasitol; 1981 Sep; 32(3):141-4. PubMed ID: 6285561
[TBL] [Abstract][Full Text] [Related]
3. [Ivory Coast uprising and returning Burkinabe immigrants: evaluation of the risk for reemergence of sleeping sickness in Burkina Faso].
Courtin F; Jamonneau V; Kambiré R; Solano P
Med Trop (Mars); 2010 Dec; 70(5-6):490-6. PubMed ID: 21520653
[TBL] [Abstract][Full Text] [Related]
4. Description of the first sleeping sickness case diagnosed in Burkina Faso since two decades.
Dama E; Drabo A; Kaboré J; Ouédraogo E; Coulibaly B; Ilboudo H; Kaboré J; Compaoré CF; Sakandé H; Ouédraogo M; Rayaissé JB; Courtin F; Solano P; Drabo F; Jamonneau V
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006677. PubMed ID: 30125276
[TBL] [Abstract][Full Text] [Related]
5. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
6. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Miezan TW; Dje NN; Doua F; Boa F
Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part II. Parasitological and immunodiagnostic examination of the human population.
Felgner P; Brinkmann U; Zillmann U; Mehlitz D; Abu-Ishira S
Tropenmed Parasitol; 1981 Sep; 32(3):134-40. PubMed ID: 6285560
[TBL] [Abstract][Full Text] [Related]
8. [History of an epidemiological route between Ivory Coast and Burkina Faso: the case of the Koudougou sleeping sickness foci].
Kiendrébéogo D; Kambiré R; Jamonneau V; Lingué K; Solano P; Courtin F
Parasite; 2012 Nov; 19(4):397-406. PubMed ID: 23193525
[TBL] [Abstract][Full Text] [Related]
9. [Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies].
Kambiré R; Lingué K; Courtin F; Sidibé I; Kiendrébéogo D; N'gouan KE; Blé L; Kaba D; Koffi M; Solano P; Bucheton B; Jamonneau V
Parasite; 2012 Nov; 19(4):389-96. PubMed ID: 23193524
[TBL] [Abstract][Full Text] [Related]
10. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
Chappuis F
Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
[No Abstract] [Full Text] [Related]
11. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
Schlitzer M
Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
[No Abstract] [Full Text] [Related]
12. [Human African trypanosomiasis: description of two pediatric cases in Yaoundé, Cameroon].
Kinkela MN; Chelo D; Boula A; Ebo'O Eyenga V; Kohagne Tongue L; Akazong CA; Kyebyene A; Tietche F
Med Trop (Mars); 2010 Feb; 70(1):73-6. PubMed ID: 20337121
[TBL] [Abstract][Full Text] [Related]
13. [Human African trypanosomiasis in the mangrove forest in Guinea: epidemiological and clinical features in two adjacent outbreak areas].
Camara M; Kaba D; KagbaDouno M; Sanon JR; Ouendeno FF; Solano P
Med Trop (Mars); 2005; 65(2):155-61. PubMed ID: 16038356
[TBL] [Abstract][Full Text] [Related]
14. Human trypanosomiasis in the Ivory Coast: therapy and problems.
Doua F; Yapo FB
Acta Trop; 1993 Sep; 54(3-4):163-8. PubMed ID: 7902655
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part I. Review of literature and description of the study areas.
Mehlitz D; Brinkmann U; Haller L
Tropenmed Parasitol; 1981 Sep; 32(3):129-33. PubMed ID: 6285559
[TBL] [Abstract][Full Text] [Related]
16. [The impact of war on the evolution of sleeping sickness in west-central Côte d'Ivoire].
Kaba D; Dje NN; Courtin F; Oke E; Koffi M; Garcia A; Jamonneau V; Solano P
Trop Med Int Health; 2006 Feb; 11(2):136-43. PubMed ID: 16451337
[TBL] [Abstract][Full Text] [Related]
17. [Three patients with African sleeping sickness following a visit to Tanzania].
Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
[TBL] [Abstract][Full Text] [Related]
18. Production of sleeping-sickness treatment.
Pécoul B; Gastellu M
Lancet; 1999 Sep; 354(9182):955-6. PubMed ID: 10489988
[No Abstract] [Full Text] [Related]
19. [The return of sleeping sickness in an epidemic form: international action for drugs].
Kager PA
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
[TBL] [Abstract][Full Text] [Related]
20. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
Robays J; Raguenaud ME; Josenando T; Boelaert M
Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
